home.social

#medical-science — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #medical-science, aggregated by home.social.

fetched live
  1. New Algae Robots Swarm Like Locusts at the Flick of a Switch. Via @singularityhub #Science 🔭🔬🧪🥼🧑‍🔬 #MedicalScience 💉💊🏥🩸😷

    New Algae Robots Swarm Like Lo...

  2. One Rare Condition Seems to Protect The Brain From Schizophrenia. Via @sciencealert #MedicalScience 💉💊🏥🩸😷 #neurology

    One Rare Condition Seems to Pr...

  3. Обычно путь от лабораторного открытия до аптечного прилавка занимает **10–15 лет**, но история знает исключения, когда научный прорыв внедрялся в практику с невероятной скоростью.
    Ниже приведены примеры самых быстрых «прыжков» из лаборатории в клинику:
    ### 1. Вакцины против COVID-19 (2020) — **~11 месяцев**
    Это абсолютный рекорд в истории современной медицины.
    * **Событие:** С момента публикации генетического кода вируса SARS-CoV-2 (январь 2020) до одобрения первой вакцины (декабрь 2020) прошло менее года.
    * **Почему так быстро:** Использование готовых платформ мРНК, огромные инвестиции и совмещение фаз клинических испытаний.
    ### 2. Инсулин (1921–1922) — **~8 месяцев**
    Один из самых драматичных и быстрых примеров спасения жизней.
    * **Открытие:** Фредерик Бантинг и Чарльз Бест выделили инсулин летом 1921 года.
    * **Внедрение:** Уже в январе 1922 года первую инъекцию получил 14-летний Леонард Томпсон, находившийся при смерти. Массовое производство началось практически сразу.
    ### 3. Пенициллин (во время Второй мировой войны) — **~3–4 года**
    Хотя Александр Флеминг открыл его в 1928 году, вещество оставалось «лабораторным курьезом» более 10 лет.
    * **Рывок:** В 1940 году группа Флори и Чейна доказала эффективность на мышах. К 1943–1944 годам, под давлением нужд фронта, США развернули промышленное производство, превратив научную статью в стандарт лечения инфекций за считанные годы.
    ### 4. Современные таргетные препараты (Осимертиниб) — **~2.7 года**
    В сфере онкологии обычно всё очень долго, но препарат **Osimertinib** (для лечения рака легких) прошел путь от первых тестов на людях до одобрения FDA невероятно быстро.
    * **Срок:** Первая фаза испытаний началась в марте 2013 года, а ускоренное одобрение было получено уже в ноябре 2015 года (всего **984 дня**).
    ### 5. Диэтиловый эфир (анестезия, 1846) — **несколько недель**
    Пример того, как открытие распространялось до появления жесткого регулирования.
    * **Событие:** 16 октября 1846 года Уильям Мортон публично продемонстрировал эфирный наркоз.
    * **Внедрение:** Уже через несколько месяцев операции под наркозом начали проводить по всему миру, включая Европу и Российскую империю (Николай Пирогов применил его в полевых условиях уже в 1847 году).
    ### Что мешает делать это быстрее сегодня?
    Сегодня средний срок в 12 лет обусловлен не медлительностью ученых, а **безопасностью**:
    1. **Клинические фазы:** Проверка на токсичность, эффективность и отдаленные последствия.
    2. **Регуляция:** Бюрократические фильтры (FDA, EMA), которые отсеивают до 90% кандидатов на стадии испытаний.
    3. **«Долина смерти»:** Проблема финансирования этапа между лабораторным успехом и началом дорогих испытаний на людях.
    **Будущее:** С применением **ИИ** (как в случае с антибиотиком *Halicin* или препаратом *DSP-1181*) этап поиска нужной молекулы сокращается с лет до месяцев, что в теории может ускорить весь цикл разработки лекарств в 2–3 раза.

    bastyon.com/post?s=b530c136bea

    Вот подборка хэштегов, разделенных по тематикам, которые соответствуют контексту медицинских прорывов и технологий:
    ### Основные (на русском)
    #медицина #наука #здоровье #технологии #инновации #открытия #биотехнологии #будущее #врачи #фармацевтика
    ### Профессиональные и узкие
    #medicalscience #biotech #Rnd #клиническиеисследования #мРНК #геннаяинженерия #фарма #medtech
    ### Тренды и ИИ
    #AIinMedicine #ИИвмедицине #цифроваямедицина #HealthTech #Biohacking #биохакинг
    ### Исторический контекст
    #историямедицины #научныйпрорыв #пенициллин #инсулин #научныйфакт
    ### Для охватов (на английском)
    #medicine #science #breakthrough #innovation #healthcare #futureofmedicine #medicaldiscovery
    **Совет:** Если вы планируете пост в Telegram или Instagram, лучше использовать 5–7 наиболее релевантных хэштегов (например, 2 широких, 2 тематических и 1–2 на английском), чтобы не перегружать текст и не попадать под фильтры спама.

    Этот материал публикуется под лицензией **Creative Commons Attribution 4.0 (CC BY 4.0)**. Вы можете свободно копировать, изменять и использовать этот текст в любых целях (включая коммерческие). Обязательное условие — указание авторства и ссылки на источник.

  4. Some gene therapies no longer require clinical trials, thanks to new FDA rule. Is this safe, and who will it help?. Via @live_science #Health ❤️‍🩹 🧑‍⚕️ #MedicalScience 💉💊🏥🩸😷 #Science #CRISPR 🔭🔬🧪🥼🧑‍🔬

    Some gene therapies no longer ...

  5. A Single Dose of Psilocybin Induces Lasting Brain Changes, New Study Suggests. Via @sciencealert #Health ❤️‍🩹 🧑‍⚕️ #MedicalScience 💉💊🏥🩸😷 #neurology

    A Single Dose of Psilocybin In...

  6. How a vision-restoring gene therapy proved that we can treat inherited diseases. Via @scientific_american #Science 🔭🔬🧪🥼🧑‍🔬 #MedicalScience 💉💊🏥🩸😷

    How a vision-restoring gene th...

  7. World ‘unprepared’ for next pandemic as countries fail to agree on sharing information, tests and vaccines. Via @guardian #Health ❤️‍🩹 🧑‍⚕️ #MedicalScience 💉💊🏥🩸😷

    World ‘unprepared’ for next pa...

  8. What My Father’s Experience Taught Me About Memory and the Brain. Via @nytimes #Health ❤️‍🩹 🧑‍⚕️ #MedicalScience 💉💊🏥🩸😷 #neurology

    nytimes.com/2026/05/07/sci...

  9. The brain's memory center doesn't start as a blank slate, study suggests. Via @live_science #Science 🔭🔬🧪🥼🧑‍🔬 #MedicalScience 💉💊🏥🩸😷 #neurology

    The brain's memory center does...

  10. Johnson & Johnson completes clinical study for OTTAVA robotic surgical system - Via @therobotreport #AI #ArtificialIntelligence 💻 🧠 #MedicalScience 💉💊🏥🩸😷 #Robotics 🤖

    Johnson & Johnson completes cl...

  11. An AI Just Beat Doctors at Diagnosing ER Patients. Via @singularityhub #AI #ArtificialIntelligence 💻 🤖 🧠 #MedicalScience 💉💊🏥🩸😷

    An AI Just Beat Doctors at Dia...

  12. Some Signs of Depression May Show Up in Blood, Study Finds. Via @sciencealert #Health ❤️‍🩹 🧑‍⚕️ #MedicalScience 💉💊🏥🩸😷 #neurology #MentalHealth

    Some Signs of Depression May S...

  13. Seattle Statement on Glyphosate and Public Health

    This statement was finalized and adopted at the Seattle Glyphosate Symposium, which took place 25-26 March, 2026 in Seattle, Washington. The statement’s authors are listed below.

    Glyphosate, a broad-spectrum herbicide (plant killer) typically marketed as Roundup, is the world’s most widely used pesticide. The diversity and magnitude of glyphosate uses in agriculture, in forestry and in industrial, commercial, residential and municipal settings have grown dramatically since first approval in 1974. 

    Humans are exposed to glyphosate through direct spraying and other skin contact, through occupational or residential proximity to sprayed areas, through exposure to dust and through consumption of food and water contaminated with glyphosate residues. Food is the main route of exposure for most people while occupational exposures are typically the highest.

    National and international biomonitoring surveys detect glyphosate in samples collected from 70-80% of all people examined, including children.

    Glyphosate and glyphosate-based herbicides (GBHs) harm human health and can cause cancer. The comprehensive evidence supports this conclusion, with the strongest epidemiological evidence linking exposure to increased risk of non-Hodgkin lymphoma, a cancer of the lymphatic system.

    There is additional evidence from human and/or animal studies that glyphosate and GBHs increase the risk of multiple adverse health effects in addition to cancer, including diseases of the kidney and liver, and impacts to the reproductive, endocrine, neurological, and other metabolic systems. Children, infants and fetuses are the most susceptible. 

    Further strong evidence finds that glyphosate and GBHs cause genetic damage, oxidative stress, and hormonal disruption — biological changes that can set disease in motion. Our understanding of glyphosate’s ability to cause these changes has developed from multiple lines of evidence in animal, human and in vitro studies.

    Additional research is needed to better understand the full extent of glyphosate’s and GBH’s effects on human health and the underlying mechanisms involved, such as epigenetic alterations, microbiome disruption and endocrine effects. 

    The evidence that glyphosate and GBHs harm human health at levels of current use is now so strong that no additional delays in regulation of glyphosate can be justified. Regulatory agencies in countries around the world should treat glyphosate and GBHs as hazardous, as some countries have started to do. Agencies should act without further delay to limit their use, or eliminate them if legally required, to protect public health. 

    Preventive measures to reduce human exposures while handling and applying glyphosate are accessible, proven effective, and inexpensive. These actions should be implemented without delay while research continues.

    Safeguards must be implemented to ensure that any reduction in glyphosate use does not result in regrettable increases in the use of other equally or more harmful pesticides, for example paraquat. 

    Glyphosate is not the only pesticide that has been inadequately evaluated or regulated. The approval processes globally for all existing and new pesticides are weak and fail to protect human health, especially the health of infants and children. This system needs to be fundamentally revised. Regulatory agencies need to make pesticide approval decisions based on a more comprehensive and unbiased suite of health effects data. If pesticide use is approved, these agencies must closely monitor use, exposure data and harmful outcomes, especially for susceptible and highly exposed groups. The costs of obtaining such data must be borne by the pesticide industry, but the testing must be conducted by laboratories and organizations independent of the pesticide industry and free from financial conflicts of interest (COI), defined as funding from industries and trade associations that have a financial stake in the outcome.

    Risk-assessment methods and processes used to evaluate pesticides must be updated to use best-available science, including: using transparent, consistent and unbiased approaches to evaluate all the evidence; accounting for human variability and susceptible populations such as fetuses, infants and children, and highly exposed populations such as farmworkers; accounting for cumulative exposures and risks for pesticides that contribute to common adverse health outcomes; and identifying adverse health effects and risks at all exposure levels. This is clearly not the case now.

    All scientific evidence used in pesticide evaluations must be publicly available, not labeled proprietary or restricted to active ingredients, and must comply with laws protecting human subjects in research. Financial COI, which do not include government funding, must be addressed throughout the research and regulatory processes, including accounting for bias from industry-funded studies, and ensuring that individuals with financial COI are barred from participating in scientific advisory panels and other bodies that formally review scientific data.

    Ultimately, pesticide use must be reduced overall, and eliminated to the extent possible. This is consistent with the United Nations Global Biodiversity Framework global target to reduce pesticide risks by 50% by 2030 relative to 2010–2020 and replace pesticides with safer, more sustainable pest control systems that rely more on prevention than treatment. This is imperative for the health of humans, ecosystems and future generations.

    link

    Signed by (Affiliations noted for identification purposes only)

    Lianne Sheppard, PhD
    University of Washington, Seattle, Washington

    Nathan Donley, PhD
    Center for Biological Diversity, Olympia, Washington

    Cynthia Curl, MS, PhD
    School of Public and Population Health, Boise State University, Boise, Idaho

    Luoping Zhang, PhD, MS
    School of Public Health, University of California, Berkeley, California

    Rashmi Joglekar, PhD
    Stanford University, Palo Alto, California

    Dr. Kurt Straif, MD, PhD
    Boston College, Massachusetts, and ISGlobal, Barcelona, Spain

    Audrey E. Tran Lam, MPH
    Center for Energy & Environmental Education, University of Northern Iowa, Cedar Falls, Iowa

    Dr. Lee A. Evslin, MD, FAAP
    Hawaii Chapter of the American Academy of Pediatrics, Kapaa, Hawaii

    Alice Livingston-Ortolani, PhD
    University of Sussex, Brighton, United Kingdom

    Brenda Eskenazi, PhD
    School of Public Health, University of California at Berkeley, Berkeley, California

    Peter Clausing, PhD
    Pesticide Action Network, Germany

    Maryse F. Bouchard, PhD
    Institut national de la recherche scientifique, Montréal, Canada

    Robin Mesnage, PhD
    King’s College London, Department of Nutritional Sciences, Germany

    Naomi Oreskes, PhD
    Harvard University, Cambridge, Massachusetts

    Grant Hopkins
    University of Washington, Seattle, Washington

    Robert Gunier, PhD
    School of Public Health, University of California at Berkeley, Berkeley, California

    Naila Khalil, MBBS, MPH, PhD
    Wright State University, Dayton, Ohio

    Amanda Claire Starbuck, MA
    Food & Water Watch, Longmont, Colorado

    Johann Zaller, PhD
    BOKU University, Institute of Zoology, Vienna, Austria

    Dr. Janet Perlman, MD, MPH, FAAP
    University of California at San Francisco, Berkeley, California

    Dr. Eve Shapiro, MD, MPH
    Fellow of the American Academy of Pediatrics, Tucson, Arizona

    Dr. Dianne Glover, MD
    Providence/Swedish Medical Center, Seattle, Washington

    Sun-Young Kim, PhD
    National Cancer Center of Korea, Goyang, Korea

    Muhammad Zahid, PhD, MPH
    College of Public Health, University of Nebraska Medical Center, Omaha, Nebraska

    Andrew Smith, PhD
    Chief Scientific Officer, Rodale Institute, Kutztown, Pennsylvania

    Tracey Woodruff, PhD, MPH
    Stanford University, Palo Alto, California

    Dr. Philip J. Landrigan, MD, MSc, FAAP
    Boston College, Boston, Massachusetts

    Christopher J. Portier, PhD
    Former Director, Agency for Toxic Substances and Disease Registry, Former Director, National Center for Environmental Health, Former Associate Director, National Toxicology Program, Thune, Switzerland

    Dr. Daniele Mandrioli, MD, PhD
    Secretary General, Collegium Ramazzini, Bologna, Italy

    Dr. Bruce Lanphear, MD, MPH
    Simon Fraser University, Vancouver, Canada

    Charles Benbrook, PhD
    Benbrook Consulting Services, Lakeville, Maine

    Dr. Beate Ritz, MD, PhD, FSPH
    University of California at Los Angeles, Los Angeles, California

    Alexandra Muñoz, MS, PhD
    Independent Toxicologist, Miami, Florida

    Anne Riederer, PhD
    University of Washington, Seattle, Washington

    Jennifer Fung, PhD
    University of California at San Francisco, San Francisco, California

    Catherine Hong
    University of Washington, Seattle, Washington

    Karie L. Knoke
    Benbrook Consulting Service, Sandpoint, Idaho

    Dr. Dennis D. Weisenburger, MD
    University of Nebraska Medical Center, Omaha, Nebraska

    Alexander A. Kaurov, PhD
    Te Herenga Waka—Victoria University of Wellington, Wellington, New Zealand

    Kelly Ryerson, MBA
    American Regeneration, Miami, Florida

    Yogi Hendlin, PhD
    Erasmus University Rotterdam, Rotterdam, The Netherlands

    Melinda Hemmelgarn, MS, RD
    Beyond Pesticides, Columbia, Missouri

    Kendra Klein, PhD
    Friends of the Earth, Washington D.C.

    Erik Millstone, PhD
    Science Policy Research Unit, University of Sussex, England, United Kingdom

    Noreen Mucha, MPA
    Wisconsin Organics, Waukesha, Wisconsin

    Dr. Kambria Beck Holder, MD
    Family Physician, Kilauea, Hawaii

    Dr. Stephanie Blount, MD
    Pediatrician, West Palm Beach, Florida

    Carsten A. Brühl, PhD
    Technical University Kaiserslautern – Landau, Institute for Environmental Sciences, Landau, Germany

    Dr. Ana M. Mora, MD, PhD
    School of Public Health, University of California at Berkeley, Berkeley, California

    Dr. Michael W. Schwartz, MD
    Professor of Medicine, University of Washington, Seattle, Washington

    #BigGovt #health #law #medicalScience #poison
  14. Why Your Brain Can Read Scrambled Words, According to Science. Via @sciencealert #Science 🔭🔬🧪🥼🧑‍🔬 #MedicalScience 💉💊🏥🩸😷 #neurology

    Why Your Brain Can Read Scramb...

  15. Here's Why Your Brain Shuts Down During Arguments, And What Helps. Via @sciencealert #MedicalScience 💉💊🏥🩸😷 #neurology #MentalHealth

    Here's Why Your Brain Shuts Do...

  16. AI can reason like a physician—what comes next? Via @sciencemagazine #AI #ArtificialIntelligence 💻 🤖 🧠 #Health ❤️‍🩹 🧑‍⚕️ #MedicalScience 💉💊🏥🩸😷

    AI can reason like a physician...

  17. IMHO: Any law restricting scientifically proven medical care is MALPRACTICE, and should be litigated as such.
    Politicians are not Doctors, and have no right to deny medical care on any basis. Abortion, Vaccines, Transgender care - all of it is not in the purview of non medically educated politicians, and every single one of them who proposes or supports these laws needs to be sued for malpractice and interference, until it is not politically acceptable to interfere.
    #USPol #MedicalScience #Law

  18. The Discovery of Stem Cells

    Canadian scientists James Till and Ernest McCulloch proved the existence of stem cells in 1961, opening doors to regenerative medicine and cancer research. Their work remains foundational in medical science. 🧬

    🇨🇦 #Canada #MedicalScience #StemCells #Research

    thecanadianencyclopedia.ca/en/

  19. AI Can Spot Pancreatic Cancer Years Before Diagnosis, Study Finds. Via @sciencealert #AI #ArtificialIntelligence 💻 🤖 🧠 #MedicalScience 💉💊🏥🩸😷 #Oncology

    AI Can Spot Pancreatic Cancer ...

  20. AI outperforms doctors in Harvard trial of emergency triage diagnoses. Via @guardian #AI #ArtificialIntelligence 💻 🤖 🧠 #MedicalScience 💉💊🏥🩸😷

    AI outperforms doctors in Harv...

  21. Active-duty US soldiers to receive MDMA therapy for PTSD next year. Via @guardian #Health ❤️‍🩹 🧑‍⚕️ #MedicalScience 💉💊🏥🩸😷 #MentalHealth #Veterans 🇺🇸

    Active-duty US soldiers to rec...

  22. In the 1930s, Robert E. Cornish Constructed a Bizarre Tilting Table to Reverse Death.
    His story continues to fascinate because of its blend of brilliance, ambition, ethical questions, and the visually striking image of a body rocking on a giant see-saw in a desperate bid to cheat death
    vintag.es/2026/05/robert-e-cor #globalmuseum #death #medicalscience

  23. How Does Imagination Really Work in the Brain? New Theory Upends What We Knew. Via @singularityhub #Science 🔭🔬🧪🥼🧑‍🔬 #MedicalScience 💉💊🏥🩸😷 #neurology

    How Does Imagination Really Wo...

  24. Student Finds the Psychedelic Fungus the Inventor of LSD Spent His Life Searching For

    The discovery could reshape how we study psychedelic compounds in nature and medicine

    At West Virginia University (WVU), Corinne Hazel, an undergraduate major in environmental microbiology, examined morning glory plants for signs of protective chemicals. She wasn’t looking for new drugs or anything psychedelic. But nestled in the folds of a tiny seed coat was a hint of white fuzz.

    That fuzz turned out to be a fungus that scientists had been seeking since the 1930s. And this included Albert Hofmann, the Swiss chemist who first synthesized LSD.

    Hofmann offered the world LSD in the late 1930s by modifying a compound called lysergic acid, which he extracted from the ergot fungus Claviceps purpurea. That fungus grows on rye and other grains and is well-known for producing ergot alkaloids, a group of chemicals that can be toxic or medicinal depending on the dose.

    Hofmann and others searched the plants for a fungus related to Claviceps purpurea, the rye-dwelling microbe that produces ergot alkaloids, a group of potent compounds with powerful biological effects. But for decades, that fungus remained a phantom.

    Hazel found it almost by accident.

    “We had a ton of plants lying around and they had these tiny little seed coats,” she said. “We noticed a little bit of fuzz in the seed coat. That was our fungus.”

    With Panaccione’s guidance, Hazel extracted DNA from the fuzz and sent it for sequencing. The results confirmed what generations of chemists and botanists had only suspected: the morning glory harbored a previously unknown species of ergot-producing fungus.

    “Sequencing a genome is a significant thing,” Panaccione said. “It’s amazing for a student.”

    link

    #brainScience #medicalScience #science
  25. Your Pleasant Memories Can Vanish For a Surprisingly Simple Reason. Via @sciencealert #Health ❤️‍🩹 🧑‍⚕️ #MedicalScience 💉💊🏥🩸😷 #neurology #MentalHealth

    Your Pleasant Memories Can Van...

  26. Health Freedom Defense Fund: ‘Your voice matters more than you can imagine’

    Leah Wilson just said the quiet part out loud:

    “Health freedom is the largest, strongest single issue voting bloc in America today.”

    “We are America’s new majority.”

    “We are independent from any party.”

    “And we are stronger than ever.”

    She declared that Bayer-Monsanto’s push for a pesticide liability shield is “exactly what happened in 1986 when Congress gave a liability shield to vaccine makers.”

    “It was a bad use of tort reform then, and it’s a bad use with pesticides today.”

    “So let the record show, just like we did in 2024, we’re gonna show up and decide the elections in 2026.”

    “Your voice matters more than you can imagine.”

    “And it’s about to matter even more in the 2026 midterm elections.”

    link

    #BigGovt #BigPharma #freedom #health #law #medicalScience #pragmatism